Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Meso Scale Discovery U-PLEX NHP IL-13 ASY
SDP

Catalog No. 5000079903
Encompass

The Meso Scale Discovery U-PLEX NHP IL-13 Assay is an electrochemiluminescent immunoassay for the quantitative measurement of human interleukin 13 (IL-13) in serum plasma and cell culture supernatants This assay utilizes MSD s proprietary SULFO-TAG labels and multi-array technology to provide sensitive and reproducible quantitation of IL-13 with a lower limit of detection of 0 07 pg/mL and an upper limit of quantification of 2500 pg/mL The assay can be multiplexed with other U-PLEX biomarkers and run on MSD s QuickPlex SQ 120 instrument in as little as 3 5 hours This assay allows for the accurate quantitation of IL-13 levels in biological samples

Catalog No. 50-000-79903 Supplier Meso Scale Discovery Supplier No. K156UBK2
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

The Meso Scale Discovery U-PLEX NHP IL-13 Assay is an electrochemiluminescent immunoassay for the quantitative measurement of human interleukin 13 (IL-13) in serum plasma and cell culture supernatants This assay utilizes MSD s proprietary SULFO-TAG labels and multi-array technology to provide sensitive and reproducible quantitation of IL-13 with a lower limit of detection of 0 07 pg/mL and an upper limit of quantification of 2500 pg/mL The assay can be multiplexed with other U-PLEX biomarkers and run on MSD s QuickPlex SQ 120 instrument in as little as 3 5 hours This assay allows for the accurate quantitation of IL-13 levels in biological samples

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.